Company Filing History:
Years Active: 2024
Title: Innovations of Jonathan Hulce
Introduction
Jonathan Hulce is an accomplished inventor based in La Jolla, California. He has made significant contributions to the field of immunotherapy, particularly in the development of compounds that modulate ABHD12. His work is crucial in the fight against cancer and infectious diseases.
Latest Patents
Jonathan holds a patent for "ABHD12 inhibitors and methods of making and using same." This patent describes compounds and compositions that serve as modulators of ABHD12. The subject compounds are particularly useful as immunotherapies, providing new avenues for treatment in various medical conditions.
Career Highlights
Jonathan is affiliated with The Scripps Research Institute, where he conducts his research and development. His work at this prestigious institution has allowed him to explore innovative solutions in the medical field.
Collaborations
Some of his notable coworkers include Daisuke Ogasawara and Taka-Aki Ichu. Their collaborative efforts contribute to the advancement of research in immunotherapy and related fields.
Conclusion
Jonathan Hulce's innovative work in developing ABHD12 inhibitors showcases his commitment to advancing medical science. His contributions are paving the way for new treatments that could significantly impact patient care.